Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06593093Phase 4Completed
Phase 4, open-label, single-arm trial in opioid use disorder (OUD) and opioid overdose, sponsored by University of Alabama at Birmingham. Primary endpoint: Participant Enrollment and Retention Rates at 3 months. Started Feb 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06593093.